Diagnostic Methods: Pattern Analysis, 7-Point Checklist, Comparative Approach
How to choose between gestalt pattern analysis, the revised seven-point checklist, the ABCD rule, the Menzies method, and the comparative ugly-duckling approach in real practice.
In brief
Once a lesion is classified as melanocytic, several validated algorithms can guide the benign-versus-melanoma decision. Pattern analysis remains the reference method, with the highest specificity in expert hands. Simplified algorithms (ABCD rule, Menzies method, seven-point checklist, including its revised lower-threshold version) trade specificity for ease of learning. The comparative approach adds a patient-level layer that none of the lesion-level algorithms capture. This topic explains how each method is built, when to use it, and how they combine in current clinical practice.
Clinical content
01Pattern analysis is the original method, in which the lesion is examined for global pattern (reticular, globular, cobblestone, homogeneous, starburst, parallel, multicomponent, nonspecific) and for local features (network, dots and globules, streaks, blue-whitish veil, regression, hypopigmentation, blotches, vascular structures). The diagnosis emerges from the overall configuration rather than a numeric score. In the CNMD validation across 108 lesions, pattern analysis produced the highest specificity (83.4%) and the best positive likelihood ratio (5.1), with sensitivity of 83.7%. It remains the preferred method of most expert dermoscopists but requires substantial training to deploy reliably.
02The ABCD rule of dermoscopy assigns weighted points to four parameters: Asymmetry (0-2, weight 1.3), Border abruptness in eight segments (0-8, weight 0.1), Color count out of six possible colors (1-6, weight 0.5), and Dermoscopic structures count (1-5, weight 0.5). The total score interprets as below 4.75 benign, 4.75 to 5.45 suspicious (close follow-up or excision), and above 5.45 highly suspicious for melanoma. Sensitivity in the CNMD was 82.6% but specificity was lower at 70%. The asymmetry parameter alone carried the highest odds ratio (13.7 for two-axis asymmetry).
03The Menzies method requires both negative features (symmetry of pattern across all axes through the lesion centroid AND single color) to be absent for a melanoma diagnosis. If both negative features are present, the lesion is benign. If at least one of the nine positive features (blue-white veil, multiple brown dots, pseudopods, radial streaming, scar-like depigmentation, peripheral black dots/globules, multiple colors, multiple blue-gray dots, broadened network) is present and at least one negative feature is absent, the lesion is diagnosed as melanoma. CNMD sensitivity was 85.7%, specificity 71.1%.
04The seven-point checklist scores three major criteria (atypical network, blue-white veil, atypical vascular pattern) at 2 points each and four minor criteria (irregular streaks, irregular dots/globules, irregular blotches, regression structures) at 1 point each. A total score of 3 or more recommends excision. In the original 1998 study sensitivity was 95% and specificity 75%. Subsequent investigations showed sensitivity ranging from 78% to 100% and specificity from 65% to 87%, depending on the case mix.
05The revised seven-point checklist (Argenziano 2011) addressed a clinical reality: contemporary melanomas are thinner and more inconspicuous than those used to validate the original algorithm. The revision assigns 1 point to every criterion (no major-minor distinction) and lowers the threshold for excision to 1 point. Tested on 100 excised melanomas, 100 excised nevi, and 100 monitored nevi, the revised threshold raised sensitivity from 77.9% to 87.8%, with specificity falling moderately from 85.6% to 74.5%. Atypical network and regression structures emerged as the most sensitive single criteria (each present in about 62% of melanomas).
06The CNMD compared the four lesion-level algorithms head-to-head. All achieved fair to good interobserver agreement and good to excellent intraobserver agreement on the final diagnosis, but pattern analysis was significantly more specific than the simplified methods (P less than .001). Sensitivity differences were smaller. The simplified algorithms were designed for non-experts, accepting reduced specificity to preserve sensitivity. The pragmatic implication is that experienced clinicians should rely on pattern analysis with a low threshold for adding the revised seven-point checklist when uncertainty arises.
07The comparative approach (Argenziano 2011) addresses the patient with multiple atypical nevi, in whom lesion-by-lesion morphologic analysis triggers excessive excisions. Six dermoscopists evaluated 190 lesions from 17 patients with multiple nevi, first individually (morphologic approach) and then grouped by patient (comparative approach). Excision recommendations dropped from 55.1% to 14.1% when lesions were viewed in the context of the same patient's other nevi. Both melanomas in the dataset were correctly identified by all six observers in both rounds. The number-needed-to-excise dropped from 52.3 to 13.4. The comparative approach formalizes the ugly duckling concept and the signature nevus concept: most individuals have a predominant nevus phenotype, and the lesion that does not fit the patient's pattern is the one that warrants attention.
08In contemporary practice the three methods are layered, not chosen exclusively. The clinician applies pattern analysis as the primary engine, falls back to the revised seven-point checklist when the pattern is ambiguous, and overlays the comparative approach across the patient's full nevus pool. Sequential digital dermoscopy imaging and short-term monitoring (covered in the management topic) supplement morphology when the answer cannot be reached at first visit.
Key dermoscopic features
High yield clinical points13 pearls in 4 groups
Recognition & pattern analysis
4 pointsDiagnostic criteria & thresholds
3 pointsPitfalls & mimics
2 pointsWhen to biopsy
4 pointsLectures covering this topic10 lectures
Notable updates & conceptual milestones6 updates
Revised seven-point checklist with threshold of one
2011 publication, broadly adopted post-2015Argenziano 2011 revision boosted sensitivity from 77.9% to 87.8% on contemporary thin melanomas while keeping specificity acceptable (74.5%). Now widely adopted in screening clinics.
Comparative-approach formalization
2011 publicationArgenziano 2011 quantified the ugly duckling concept under dermoscopy. Reduced excision rate from 55% to 14% and NNE from 52 to 13 in multiple-nevus patients.
Sequential digital dermoscopy imaging (SDDI)
Refined through 2009-2024Side-by-side comparison of stored baseline images at 3 months catches morphologically featureless incipient melanomas; integrated into the modern algorithm stack.
AI-assisted pattern analysis
2022 onwardDeep-learning systems trained on consensus-labeled datasets now provide real-time pattern-analysis predictions during examination, used as a second reader.
Total-body photography paired with dermoscopy (the two-step method of digital follow-up)
Mature method, 2022-2026 commercial expansionWhole-body imaging linked to dermoscopic stacks in high-risk patients; improves both new-lesion detection and existing-lesion change tracking.
Chaos and Clues algorithm
Updated through 2024Rosendahl-Kittler simplified method requiring chaos (asymmetry of pattern or color) plus at least one of nine clues; alternative entry point for non-expert users.
Bottom line
How to choose between gestalt pattern analysis, the revised seven-point checklist, the ABCD rule, the Menzies method, and the comparative ugly-duckling approach in real practice.
13 clinical points · 6 recent updates · 8 references
References
Sources cited in the lecture content or that underpin the clinical points above. Verify with primary sources before practice changes.
- [1]Argenziano G, Soyer HP, Chimenti S, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol. 2003;48(5):679-693.PubMed: 12734496DOI: 10.1067/mjd.2003.281· Head-to-head comparison of pattern analysis, ABCD, Menzies, and seven-point checklist.
- [2]Argenziano G, Catricala C, Ardigo M, et al. Seven-point checklist of dermoscopy revisited. Br J Dermatol. 2011;164(4):785-790.PubMed: 21175563DOI: 10.1111/j.1365-2133.2010.10194.x· Source of the revised low-threshold seven-point checklist.
- [3]Argenziano G, Catricala C, Ardigo M, et al. Dermoscopy of patients with multiple nevi: improved management recommendations using a comparative diagnostic approach. Arch Dermatol. 2011;147(1):46-49.PubMed: 21242392· Quantitative validation of the comparative approach for multiple-nevus patients.
- [4]Argenziano G, Fabbrocini G, Carli P, De Giorgi V, Sammarco E, Delfino M. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol. 1998;134(12):1563-1570.PubMed: 9875194· Original validation of the seven-point checklist.
- [5]Stolz W, Riemann A, Cognetta AB, et al. ABCD rule of dermatoscopy: a new practical method for early recognition of malignant melanoma. Eur J Dermatol. 1994;4:521-527.· Original ABCD rule.
- [6]Menzies SW, Ingvar C, Crotty KA, McCarthy WH. Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Arch Dermatol. 1996;132(10):1178-1182.PubMed: 8859028· Foundational data underlying the Menzies method.
- [7]Grob JJ, Bonerandi JJ. The 'ugly duckling' sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. Arch Dermatol. 1998;134(1):103-104.PubMed: 9449921· Original ugly duckling concept that anchors the comparative approach.
- [8]Haenssle HA, Korpas B, Hansen-Hagge C, et al. Seven-point checklist for dermatoscopy: performance during 10 years of prospective surveillance of patients at increased melanoma risk. J Am Acad Dermatol. 2010;62(5):785-793.PubMed: 20226567· Long-term prospective performance data for the seven-point checklist in high-risk surveillance.